Grove Inc. Launches “Fund Your Brand” Option for Amazon Aggregation Initiative
November 03, 2021 08:00 ET
|
Grove, Inc.
HENDERSON, NV, Nov. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Grove, Inc. (NASDAQ:GRVI) ("Grove" or the "Company"): Grove Inc., a global innovator in hemp, health, and wellness, today...
Pacira BioSciences Reports Third Quarter 2021 Financial Results
November 03, 2021 08:00 ET
|
Pacira BioSciences
-- Third quarter GAAP net income of $17.7 million and adjusted EBITDA of $48.1 million -- -- Conference call today at 8:30 a.m. ET -- TAMPA, Fla., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pacira...
Rain Therapeutics to Report Third Quarter 2021 Financial Results and Highlights of Recent Progress on November 10, 2021
November 03, 2021 08:00 ET
|
Rain Therapeutics Inc
NEWARK, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company developing precision oncology therapeutics, today announced it will report...
Atlas Air Worldwide Reports Strong Third-Quarter Results
November 03, 2021 08:00 ET
|
Atlas Air Worldwide Holdings
Quarterly Revenue Exceeded $1.0 Billion Reported Net Income Increased to $119.5 MillionAdjusted EBITDA Grew to $280.5 MillionAdjusted Net Income Increased to $145.4 MillionExpect Record Fourth Quarter...
BrainsWay to Report Third Quarter 2021 Financial Results on November 17, 2021
November 03, 2021 08:00 ET
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
ROBIT PLC: MANAGERS’ TRANSACTIONS
November 03, 2021 08:00 ET
|
Robit Plc
ROBIT PLC MANAGERS’ TRANSACTIONS 3 NOVEMBER 2021 AT 2.00 P.M. ROBIT PLC: MANAGERS’ TRANSACTIONS Robit Oyj - Managers'...
SOTIO to Present New Data from Phase 1 Study of IL-15 Superagonist, SOT101, at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
November 03, 2021 08:00 ET
|
Sotio
SOTIO will present three posters discussing data that highlight the encouraging safety and efficacy for SOT101 (SO-C101) as a monotherapy and in combination with pembrolizumab for the treatment of...
Allena Pharmaceuticals Receives Fast Track Designation from FDA for the Development of ALLN-346 for Chronic Treatment of Hyperuricemia in Patients With Gout and Advanced Chronic Kidney Disease
November 03, 2021 08:00 ET
|
Allena Pharmaceuticals, Inc.
- Novel oral therapeutic candidate ALLN-346 targets uric acid in the intestinal tract - - Patients with gout and CKD have a serious condition with an unmet need for urate-lowering–therapies – ...
Colliers strengthens flex space offering with SmartFlex launch
November 03, 2021 08:00 ET
|
Colliers International Group Inc.
Note: Colliers SmartFlex is now Colliers360 SmartFlex (October 2023)NEW YORK and LOS ANGELES and ATLANTA and TORONTO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Colliers, a leading diversified...
COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for post-traumatic stress disorder
November 03, 2021 08:00 ET
|
COMPASS Pathways
London, UK – 3 November 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental...
- September 23, 2024 21:59 ET Arllecta Group announces its new S2S algorithm that significantly outperforms current strong GPT-solutions
- September 23, 2024 21:00 ET EBC 荣获 BrokersView “最佳交易体验” 奖，强化全球领导力